Literature DB >> 8217800

Influence of demographic factors on antithrombin III activity in a healthy population.

R C Tait1, I D Walker, S I Islam, F McCall, J A Conkie, R Mitchell, J F Davidson.   

Abstract

Antithrombin III (AT III) activity has been measured in 9669 healthy blood donors (5525 male and 4144 female). The distribution of AT III is approximately 'normal' with mean 105.6 IU/dl and standard deviation 11.2; however, definite age and sex related variations are evident. Pre-menopausal females have lower mean AT III compared to their male contemporaries who have remarkably stable mean AT III until 45 years, after which there is a gradual decline. In contrast, post-menopausal females have higher mean AT III than both males of the same age and younger pre-menopausal females. Concurrent hormone replacement therapy inhibits this rise. The use of hormonal preparations is associated with a 4 IU/dl reduction of mean AT III in younger females but not in those over 30 years. Smoking may result in a mild increase in AT III of doubtful clinical significance. On-going genetic and family studies are expected to predict a prevalence rate of congenital AT III deficiency in excess of the previously reported figure of 0.02%. The authors consider these observed variations as minor and recommend the use of a single reference range for AT III activity, but that particular care be taken when interpreting results in pill-taking females and the elderly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217800     DOI: 10.1111/j.1365-2141.1993.tb03104.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.

Authors:  Tienan Zhu; Qiulan Ding; Xia Bai; Xiaoyan Wang; Florentia Kaguelidou; Corinne Alberti; Xuqian Wei; Baolai Hua; Renchi Yang; Xuefeng Wang; Zhaoyue Wang; Changgeng Ruan; Nicole Schlegel; Yongqiang Zhao
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

2.  Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels.

Authors:  Ana I Antón; Raúl Teruel; Javier Corral; Antonia Miñano; Irene Martínez-Martínez; Adriana Ordóñez; Vicente Vicente; Beatriz Sánchez-Vega
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

3.  Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.

Authors:  Hee-Jin Kim; Ja-Young Seo; Ki-O Lee; Sung-Hwan Bang; Seung-Tae Lee; Chang-Seok Ki; Jong-Won Kim; Chul Won Jung; Duk-Kyung Kim; Sun-Hee Kim
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

Review 4.  Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.

Authors:  Peter S Maclean; R Campbell Tait
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies.

Authors:  Flavia Franconi; Ilaria Campesi; Delia Colombo; Paola Antonini
Journal:  Cells       Date:  2019-05-17       Impact factor: 6.600

Review 6.  Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update.

Authors:  Dimitra Akrivou; Garifallia Perlepe; Paraskevi Kirgou; Konstantinos I Gourgoulianis; Foteini Malli
Journal:  Medicina (Kaunas)       Date:  2022-08-10       Impact factor: 2.948

7.  Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency.

Authors:  Andra H James; Barbara A Konkle; Kenneth A Bauer
Journal:  Int J Womens Health       Date:  2013-05-03

8.  Identification of antithrombin-modulating genes. Role of LARGE, a gene encoding a bifunctional glycosyltransferase, in the secretion of proteins?

Authors:  María Eugenia de la Morena-Barrio; Alfonso Buil; Ana Isabel Antón; Irene Martínez-Martínez; Antonia Miñano; Ricardo Gutiérrez-Gallego; José Navarro-Fernández; Sonia Aguila; Juan Carlos Souto; Vicente Vicente; José Manuel Soria; Javier Corral
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.